Optimal treatment of multivessel complex coronary artery disease
1Department of Cardiology, The Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China ; Department of Cardiology, The Central Hospital of Tai'an, Tai'an, Shandong 271000, P.R. China.
Insights
For multivessel complex coronary artery disease (MCCAD), single complete revascularization (CR) resulted in fewer cardiac events and lower medical costs over three years compared to fractionated or partial revascularization.
Area of Science:
- Cardiology
- Interventional Cardiology
- Health Economics
Background:
- Multivessel complex coronary artery disease (MCCAD) poses significant challenges in treatment selection.
- Optimizing revascularization strategies is crucial for improving patient outcomes and managing healthcare costs.
Purpose of the Study:
- To compare major cardiac events and medical costs among MCCAD patients undergoing different revascularization strategies.
- To identify the optimal and most economical treatment program for MCCAD.
Main Methods:
- A retrospective study of 2,309 MCCAD patients treated over a decade.
- Patients were categorized into single complete revascularization (CR), fractionated revascularization (FR), or partial revascularization (PR) groups.
- Three-year follow-up assessed major cardiac events and associated medical costs.
Main Results:
- The CR group had a significantly lower three-year cardiac event rate (17%) compared to FR and PR groups.
- Average three-year medical costs were significantly lower in the CR group (62,100 RMB) than in the FR and PR groups.
- Single CR demonstrated superior clinical and economic benefits.
Conclusions:
- Single complete revascularization is the optimal treatment strategy for MCCAD patients when feasible.
- CR offers a more cost-effective approach, reducing both cardiac events and healthcare expenditure.
- This study highlights the importance of CR in managing complex coronary artery disease.
Abstract:
The aim of the present study was to investigate major cardiac events and the similarities and differences of medical costs among patients with multivessel complex coronary artery disease (MCCAD) during the three-year follow-up. The MCCAD patients had undergone single complete revascularization (CR), fractionated revascularization (FR) or partial revascularization (PR) and the present study aimed to screen the optimal treatment program. A total of 2,309 MCCAD patients who had been treated at a single center in the last decade, among which 1,020 cases underwent single CR, 856 cases successively underwent FR and 433 cases only underwent PR, were followed-up for three years. Major cardiac events, including all-cause mortality, myocardial infarction, severe heart failure, rehospitalization and revascularization (coronary artery bypass grafting and coronary stent reimplantation), were set as the end points. In addition, the three-year medical costs associated with heart disease were analyzed. The three-year cardiac event rate in the CR group (17%) was significantly lower compared with the other two groups and the average three-year medical costs in the CR group (62,100 RMB) were significantly lower than those in the other two groups. Therefore, under permissive conditions, single CR is the optimal and most economical treatment strategy for patients with MCCAD.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
